Stock Analysis
Data Source: SEC EDGAR 13F
Updated Hourly

Alaunos Therapeutics Inc (TCRT)

28 + Investors. Track Smart Money conviction in TCRT. See who's accumulating, reducing, or initiating positions.

Current Price
-- USD
Analyst Target
-- (0 analysts)
Upside
0.00%
Net Flow Q/Q
↑ +3
Streak
2Q ▲
Buyers last Q
63%

Smart Money Signals — TCRT

Based on 28 hedge funds · latest filing: 2026 Q1 · updated quarterly

📈

Buying streak — 2 quarters in a row

last 6Q
For 2 consecutive quarters, more hedge funds added TCRT than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.
🏔️

At the ownership peak (100% of max)

100% of all-time peak
28 hedge funds hold TCRT right now — the highest count in 3.0 years. When ownership is this concentrated, any bad news can trigger a chain reaction: one big fund sells, others follow. This is a classic 'crowded trade' — high popularity doesn't equal safety.
📶

Steady growth — +8% more funds vs a year ago

fund count last 6Q
+2 new funds entered over the past year (+8% YoY). Gradual, steady growth in institutional ownership is generally a healthy signal — not a speculative rush, but consistent conviction.
🟢

More buyers than sellers — 63% buying

12 buying7 selling
Last quarter: 12 funds were net buyers (6 opened a brand new position + 6 added to an existing one). Only 7 were sellers (4 trimmed + 3 sold completely). A clear majority buying is a strong confirmation signal.
➡️

Steady new buyers — ~6 new funds per quarter

new funds entering per quarter
Funds opening this position for the first time: 3 → 4 → 5 → 6. A stable flow of new institutional buyers suggests ongoing interest without signs of either acceleration or slowdown.
🔄

Mostly new holders — 36% entered in last year

■ 4% conviction (2yr+) ■ 61% medium ■ 36% new
Only 1 funds (4%) have held >2 years. The majority of current holders are relatively new to the position. New holders tend to sell faster when prices drop — a shallow conviction base that could amplify any sell-off.
➡️

Steady discovery — ~6 new funds/quarter

3 → 3 → 4 → 5 → 6 new funds/Q
New funds entering each quarter: 3 → 4 → 5 → 6. Consistent flow of new institutional buyers without clear acceleration or slowdown.
📊

Mixed cohorts — 4% veterans, 36% new entrants

■ 4% veterans ■ 61% 1-2yr ■ 36% new
Of 28 current holders: 1 (4%) held 2+ years, 17 held 1–2 years, 10 (36%) entered in the past year. Balanced distribution — some institutional memory, some recent momentum buyers.
✅

Strong quality — 29% AUM from major funds

29% from top-100 AUM funds
8 of 28 holders rank in the top 100 by AUM, accounting for 29% of total institutional value held. A meaningful share of the ownership value comes from the most well-resourced institutions.
4.0
out of 10
Moderate Exit Risk
Exit risk score 4.0/10 — some crowding factors present, but no critical concentration. Watch ownership trend over the next 1–2 quarters for direction.

Methodology note: these Smart Money cards use consecutive 13F disclosure snapshots, not trade-by-trade execution data. "Buying", "selling", "new holders", and "trimmed" refer to quarter-over-quarter changes in reported holders, aggregate shares, or disclosed position values between filings. They are useful for ownership regime analysis and crowding, but they do not imply exact trade timing on the filing date.

Institutional Sentiment Summary — TCRT

In 2026 Q1, 12 hedge funds were net buyers of TCRT (6 opened a new position, 6 added to an existing one), while 7 reduced or exited (4 trimmed, 3 sold completely) — a 63% buyer ratio, indicating clear institutional accumulation. Net buying has persisted for two consecutive quarters, a positive momentum signal. 29% of total institutional value in TCRT is held by top-100 AUM funds, reflecting strong institutional quality. Net fund flow last quarter: +3 funds (more new holders than closures). Total institutional holders: 28.

Hedge Fund Ownership: TCRT

How many hedge funds hold TCRT — quarterly history vs. share price
Quarterly hedge fund ownership of TCRT vs. share price

Market Analysis: TCRT

Analyst Price Targets

Avg. Price Target
--

Analyst Recommendations

Stock Performance

Real-time

Company Profile: TCRT

-- --

Institutional ownership data sourced from SEC EDGAR Form 13F-HR filings.

Is It Too Late to Buy Alaunos Therapeutics Inc (TCRT) Based on Hedge Fund 13F Filings?

Signal Freshness measures how much TCRT has moved relative to its sector benchmark (XLV) since the 2026 Q1 13F filing. A stock that has barely outrun its sector is still a relatively fresh entry point — the fund's thesis has not yet been priced in by the broader market.

Since Quarter End March 31, 2026 · 80d ago
TCRT
nan%
XLV
+2.1%

TCRT outperformed XLV by nan% since March 31, 2026.

Since 13F Filing Date May 15, 2026 · 35d ago
TCRT
nan%
XLV
+3.2%

Since the filing became public, TCRT outperformed XLV by nan% .

Interpretation: The stock is tracking its sector benchmark closely. The signal remains fresh and the entry point is still near the fund's implied reference. Learn more →

Smart Money Signal ?
Limited Smart Money Interest

No strong consensus or elite conviction detected among institutional holders.

6 top-rated funds 0 high-conviction
Consensus
3.7
/ 10
breadth
×
Elite
0.0
/ 10
conviction
Hedge Fund Positioning: TCRT
28 + Investors

Track Smart Money conviction in TCRT. See who's accumulating, reducing, or initiating positions.

Metric All 13F Filers (2026 Q1) Prior (2025 Q4) Change
Funds Holding 28 25 12.0%
13F Shares 125K 109K 15.57%
Total Value $359K $350K 2.63%
New Positions 6 5 +1
Increased Positions 6 2 +4
Closed Positions 3 4 -1
Reduced Positions 4 6 -2
Total Calls 0 0 -
Total Puts 0 0 -
PUT/CALL Ratio 0.0 0.0 Bullish

Statistics: TCRT

View More

Valuation Measures Data as of: --

Market Cap --
Enterprise Value --
Trailing P/E --
Forward P/E --
PEG Ratio (5yr expected) --
Price/Sales (ttm) --
Price/Book (mrq) --
Enterprise Value/Revenue --
Enterprise Value/EBITDA --
Beta (5Y Monthly) --
Short Ratio (Days to Cover) --
Short % of Float --

Financial Highlights

Profitability
Profit Margin --
Return on Assets (ttm) --
Return on Equity (ttm) --
Income Statement & Cash Flow
Revenue (ttm) --
Net Income Avi to Common (ttm) --
Diluted EPS (ttm) --
Total Cash (mrq) --
Total Debt/Equity (mrq) --
Levered Free Cash Flow (ttm) --

Institutional Holders (2026 Q1)

28 + investors

Explore institutional interest and hedge fund ownership dynamics. Analyze portfolio weights, new positions, and conviction trends in TCRT. Verified SEC 13F-HR filings.

QUARTER:
Top 25 TCRT holders by conviction (% of portfolio weight) — 2026 Q1 · Source: SEC Form 13F
# Investor % of Portfolio Shares Mkt Value
1 XTX Topco Ltd 0.00% 10,174 $29K
2 Tower Research Capital LLC (TRC) 0.00% 1,583 $5K
3 Hrt Financial LP 0.00% 13,327 $38K
4 Two Sigma Investments, LP 0.00% 10,839 $31K
5 Key FInancial Inc 0.00% 24 —
6 Vanguard Fiduciary Trust Co 0.00% 15,497 $44K
7 NFSG Corp 0.00% 21 —
8 Osaic Holdings, INC. 0.00% 1,779 $5K
9 Citadel Advisors LLC 0.00% 10,519 $30K
10 Blue Trust, Inc. 0.00% 135 —
11 Nbc Securities, INC. 0.00% 20 —
12 AdvisorNet Financial, Inc 0.00% 19 —
13 Inspire Investing, LLC 0.00% 9 —
14 Sunbelt Securities, Inc. 0.00% 10 —
15 Tidemark, LLC 0.00% 2 —
16 Steward Partners Investment Advisory, LLC 0.00% 92 —
17 BlackRock, Inc. 0.00% 21,353 $61K
18 Signaturefd, LLC 0.00% 23 —
19 Vanguard Capital Management LLC 0.00% 14,063 $40K
20 UBS Group AG 0.00% 2,274 $7K
21 Federation des caisses Desjardins du Quebec 0.00% 70 —
22 Royal Bank of Canada 0.00% 185 $1K
23 Morgan Stanley 0.00% 653 $2K
24 Wells Fargo & Company/Mn 0.00% 190 —
25 Cwm, LLC 0.00% 8 —
Investor Ownership
History 		% of Portfolio Prev % Rank Conviction Avg Buy Price 13F Score™ 3Y / 7Y Sell Timing Shares Mkt Value Change Change % Source Quarter Filed

Frequently Asked Questions — Alaunos Therapeutics Inc (TCRT)

What does the Smart Money Trend signal show for TCRT?

Buying streak — 2 quarters in a row: For 2 consecutive quarters, more hedge funds added TCRT than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.

What is the institutional breadth score for TCRT?

More buyers than sellers — 63% buying: Last quarter: 12 funds were net buyers (6 opened a brand new position + 6 added to an existing one). Only 7 were sellers (4 trimmed + 3 sold completely). A clear majority buying is a strong confirmation signal.

What is the fund quality score for TCRT holders?

Strong quality — 29% AUM from major funds: 8 of 28 holders rank in the top 100 by AUM, accounting for 29% of total institutional value held. A meaningful share of the ownership value comes from the most well-resourced institutions.

How long have hedge funds held TCRT?

Mostly new holders — 36% entered in last year: Only 1 funds (4%) have held >2 years. The majority of current holders are relatively new to the position. New holders tend to sell faster when prices drop — a shallow conviction base that could amplify any sell-off.

Is it too late to buy Alaunos Therapeutics Inc (TCRT) following the 2026 Q1 hedge fund 13F filings?

As of today, TCRT has moved nan% since the 2026 Q1 13F filing date (May 15, 2026), compared to +3.2% for the XLV sector ETF — an outperformance of nan%. Since the quarter end (March 31, 2026), TCRT has gained nan% vs +2.1% for XLV. The stock is tracking its sector benchmark closely. The signal remains fresh and the entry point is still near the fund's implied reference.

Where does this institutional ownership data come from?

All holdings data is sourced from SEC Form 13F filings, which institutional investment managers with over $100 million in assets are required to submit quarterly. Data is parsed directly from SEC EDGAR.

Disclaimer: The information on this page is for informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any security. Institutional holdings data is sourced from SEC Form 13F filings and reflects positions as of the filing date. Past performance of any fund or portfolio is not indicative of future results. 13Foresight is not a registered investment adviser. Always conduct your own due diligence before making investment decisions.

Full history →